Floatz logo

Autologous Ccr4 Car T Cells

Hepatosplenic T-Cell Lymphoma

National Cancer Institute (NCI)Cell therapyPhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Hepatosplenic T-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
City of Hope Medical Center
Phase 4BBB
Inno-206
National Cancer Institute (NCI)
Phase 4BBB
Fludarabine
National Cancer Institute (NCI)
Phase 2BBB
Ifosfamide
Shandong Provincial Hospital
Phase 4BBB
PREDNISONE TABLETS
City of Hope Medical Center
Phase 4BBB

View all 50 →

Same molecule, other indications

Autologous Ccr4 Car T Cells is also rated in:

neoplasm of mature T-cells or NK-cellsDormant
CC
Indicative ·
43 / 100
View asset →
monomorphic epitheliotropic intestinal T-cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →
enteropathy-associated T-cell lymphomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →